DIANZANI, Chiara
DIANZANI, Chiara
SCIENZA E TECNOLOGIA DEL FARMACO
3D advanced human melanoma models
2017-01-01 Sorrentino, R; Squarzanti, Df; Dianzani, C; Cavalli, R; Cassoni, P; Annaratone, L; Ribero, S; Russo, R; Senetta, R; Daga, M; Barrera, G; Azzimonti, B; Pizzimenti, S
3D advanced melanoma models
2016-01-01 Azzimonti, Barbara; Landini, Manuela Miriam; Sorrentino, Rita; Dianzani, Chiara; Cavalli, Roberta; Castellano, Isabella; Annaratone, Laura; Ribero, Simone; Russo, Rosalia; Senetta, Rebecca; Daga, Martina; Barrera, Giuseppina; Pizzimenti, Stefania
A mutation in caspase-9 decreases the expression of BAFFR and ICOS in patients with immunodeficiency and lymphoproliferation
2015-01-01 Clemente, N; Boggio, E.; Gigliotti, C.L.; Orilieri, E.; Cappellano, G.; Toth, E.; Valletti, P.A.; Santoro, C.; Quinti, I.; Pignata, C.; Notarangelo, L.D.; Dianzani, C.; Dianzani, I.; Ramenghi, U.; Dianzani, U.; Chiocchetti, A.
A new bevacizumab carrier for intravitreal administration: Focus on stability
2021-01-01 Chirio D.; Peira E.; Sapino S.; Chindamo G.; Oliaro-bosso S.; Adinolfi S.; Dianzani C.; Baratta F.; Gallarate M.
A preliminary in vitro and in vivo study of the effects of new anthraquinones on neutrophils and bone remodeling
2005-01-01 SAVARINO L; BENETTI D; BALDINI N; TARABUSI C; GRECO M; ALOISI R; FRASCARELLI S; FANTOZZI R; DIANZANI C; MIAN M
A preliminary in vitro and in vivo study of the effects of new anthraquinones on neutrophils and bone remodeling.
2005-01-01 Savarino, L.; Benetti, D.; Baldini, N.; Tarabusi, C.; Greco, M.; Aloisi, R.; Frascarelli, S.; Fantozzi, R.; Dianzani, C.; Mian, M.
Adenosine modulation of primed human neutrophils
1994-01-01 Dianzani C.; Brunelleschi S.; Viano I.; Fantozzi R.
Adhesion of polymorphonuclear cells to endothelial cells is physiologically inhibited by Gas6
1998-01-01 M. Gallicchio; C. Dianzani; M. Fontana; F. Capelli; M. Vidali; F. Bottarel; M. Bragardo; N. Surico; G. Garbarino; G. Saglio; U. Dianzani; R. Fantozzi; G.C. Avanzi
Ailanthone increases oxidative stress in CDDP-resistant ovarian and bladder cancer cells by inhibiting of Nrf2 and YAP expression through a post-translational mechanism
2020-01-01 Cucci M.A.; Grattarola M.; Dianzani C.; Damia G.; Ricci F.; Roetto A.; Trotta F.; Barrera G.; Pizzimenti S.
Ailanthone inhibits cell growth and migration of cisplatin resistant bladder cancer cells through down-regulation of Nrf2, YAP, and c-Myc expression
2019-01-01 Daga, Martina; Pizzimenti, Stefania*; Dianzani, Chiara; Cucci, Marie Angele; Cavalli, Roberta; Grattarola, Margherita; Ferrara, Benedetta; Scariot, Valentina; Trotta, Francesco; Barrera, Giuseppina
Albumin nanoformulations as an innovative solution to overcome doxorubicin chemoresistance
2021-01-01 Federica Bessone, Chiara Dianzani, Monica Argenziano, Luigi Cangemi, Rita Spagnolo, Federica Maione, Enrico Giraudo, Roberta Cavalli
Aldehydic lipid peroxidation products modulate the activity of human neutrophils
1995-01-01 Dianzani C; Parrini M; Ferrara C; Fantozzi R
Aldehydic lipid peroxidation products modulate the attivity of pro-inflammatory cell.
1994-01-01 Dianzani C.; Fantozzi R
Aminoglycoside excretion in a rat kidney model
1988-01-01 Viano I.; Silvestro L.; Dianzani C.; Giovannini L.; Bertelli A.A.E. Trombi L
Analyzing Cysteine Site Neighbors in Proteins to Reveal Dimethyl Fumarate Targets
2019-01-01 Rosa A.C.; Benetti E.; Gallicchio M.; Boscaro V.; Cangemi L.; Dianzani C.; Miglio G.
Antitumor activity of nanosponge-encapsulated camptotechin in human prostate tumors.
2010-01-01 Rosalba Minelli; Roberta Cavalli; Roberto Fantozzi; Chiara Dianzani; Piergiorgio Pettazzoni ; Roberto Pili
Antitumor activity of nanosponge-encapsulated camptothecin in human prostate tumors
2011-01-01 Minelli R; Cavalli R; Fantozzi R; Dianzani C; Pettazzoni P; Ellis L; Shen L; Pili R
Antitumor effect of nanosponge-encapsulated camptothecin in human prostate tumors
2012-01-01 Minelli R.; Cavalli R.; Occhipinti S.; Gigliotti C.L.; Fantozzi R.; Giovarelli M.; Dianzani U.; Dianzani C
Antitumor effect of nanosponges-encapsulated camptothecin in human prostate tumors
2012-01-01 Minelli R; Cavalli R; Occhipinti S; Gigliotti CL; Fantozzi R; Giovarelli M; Dianzani U; Dianzani C
AS601245, an anti-inflammatory JNK inhibitor, and clofibrate have a synergistic effect in inducing cell responses and in affecting the gene expression profile, in CaCo-2 colon cancer cells.
2012-01-01 Angelo Cerbone; Cristina Toaldo; Stefania Pizzimenti; Piergiorgio Pettazzoni; Chiara Dianzani; Rosalba Minelli; Eric Ciamporcero; Guglielmo Roma; Mario Umberto Dianzani; Roberto Canaparo; Carlo Ferretti; and Giuseppina Barrera
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 3D advanced human melanoma models | 2017 | Sorrentino, R; Squarzanti, Df; Dianzani, C; Cavalli, R; Cassoni, P; Annaratone, L; Ribero, S; Russo, R; Senetta, R; Daga, M; Barrera, G; Azzimonti, B; Pizzimenti, S | |
| 3D advanced melanoma models | 2016 | Azzimonti, Barbara; Landini, Manuela Miriam; Sorrentino, Rita; Dianzani, Chiara; Cavalli, Roberta; Castellano, Isabella; Annaratone, Laura; Ribero, Simone; Russo, Rosalia; Senetta, Rebecca; Daga, Martina; Barrera, Giuseppina; Pizzimenti, Stefania | |
| A mutation in caspase-9 decreases the expression of BAFFR and ICOS in patients with immunodeficiency and lymphoproliferation | 2015 | Clemente, N; Boggio, E.; Gigliotti, C.L.; Orilieri, E.; Cappellano, G.; Toth, E.; Valletti, P.A.; Santoro, C.; Quinti, I.; Pignata, C.; Notarangelo, L.D.; Dianzani, C.; Dianzani, I.; Ramenghi, U.; Dianzani, U.; Chiocchetti, A. | |
| A new bevacizumab carrier for intravitreal administration: Focus on stability | 2021 | Chirio D.; Peira E.; Sapino S.; Chindamo G.; Oliaro-bosso S.; Adinolfi S.; Dianzani C.; Baratta F.; Gallarate M. | |
| A preliminary in vitro and in vivo study of the effects of new anthraquinones on neutrophils and bone remodeling | 2005 | SAVARINO L; BENETTI D; BALDINI N; TARABUSI C; GRECO M; ALOISI R; FRASCARELLI S; FANTOZZI R; DIANZANI C; MIAN M | |
| A preliminary in vitro and in vivo study of the effects of new anthraquinones on neutrophils and bone remodeling. | 2005 | Savarino, L.; Benetti, D.; Baldini, N.; Tarabusi, C.; Greco, M.; Aloisi, R.; Frascarelli, S.; Fantozzi, R.; Dianzani, C.; Mian, M. | |
| Adenosine modulation of primed human neutrophils | 1994 | Dianzani C.; Brunelleschi S.; Viano I.; Fantozzi R. | |
| Adhesion of polymorphonuclear cells to endothelial cells is physiologically inhibited by Gas6 | 1998 | M. Gallicchio; C. Dianzani; M. Fontana; F. Capelli; M. Vidali; F. Bottarel; M. Bragardo; N. Surico; G. Garbarino; G. Saglio; U. Dianzani; R. Fantozzi; G.C. Avanzi | |
| Ailanthone increases oxidative stress in CDDP-resistant ovarian and bladder cancer cells by inhibiting of Nrf2 and YAP expression through a post-translational mechanism | 2020 | Cucci M.A.; Grattarola M.; Dianzani C.; Damia G.; Ricci F.; Roetto A.; Trotta F.; Barrera G.; Pizzimenti S. | |
| Ailanthone inhibits cell growth and migration of cisplatin resistant bladder cancer cells through down-regulation of Nrf2, YAP, and c-Myc expression | 2019 | Daga, Martina; Pizzimenti, Stefania*; Dianzani, Chiara; Cucci, Marie Angele; Cavalli, Roberta; Grattarola, Margherita; Ferrara, Benedetta; Scariot, Valentina; Trotta, Francesco; Barrera, Giuseppina | |
| Albumin nanoformulations as an innovative solution to overcome doxorubicin chemoresistance | 2021 | Federica Bessone, Chiara Dianzani, Monica Argenziano, Luigi Cangemi, Rita Spagnolo, Federica Maione, Enrico Giraudo, Roberta Cavalli | |
| Aldehydic lipid peroxidation products modulate the activity of human neutrophils | 1995 | Dianzani C; Parrini M; Ferrara C; Fantozzi R | |
| Aldehydic lipid peroxidation products modulate the attivity of pro-inflammatory cell. | 1994 | Dianzani C.; Fantozzi R | |
| Aminoglycoside excretion in a rat kidney model | 1988 | Viano I.; Silvestro L.; Dianzani C.; Giovannini L.; Bertelli A.A.E. Trombi L | |
| Analyzing Cysteine Site Neighbors in Proteins to Reveal Dimethyl Fumarate Targets | 2019 | Rosa A.C.; Benetti E.; Gallicchio M.; Boscaro V.; Cangemi L.; Dianzani C.; Miglio G. | |
| Antitumor activity of nanosponge-encapsulated camptotechin in human prostate tumors. | 2010 | Rosalba Minelli; Roberta Cavalli; Roberto Fantozzi; Chiara Dianzani; Piergiorgio Pettazzoni ; Roberto Pili | |
| Antitumor activity of nanosponge-encapsulated camptothecin in human prostate tumors | 2011 | Minelli R; Cavalli R; Fantozzi R; Dianzani C; Pettazzoni P; Ellis L; Shen L; Pili R | |
| Antitumor effect of nanosponge-encapsulated camptothecin in human prostate tumors | 2012 | Minelli R.; Cavalli R.; Occhipinti S.; Gigliotti C.L.; Fantozzi R.; Giovarelli M.; Dianzani U.; Dianzani C | |
| Antitumor effect of nanosponges-encapsulated camptothecin in human prostate tumors | 2012 | Minelli R; Cavalli R; Occhipinti S; Gigliotti CL; Fantozzi R; Giovarelli M; Dianzani U; Dianzani C | |
| AS601245, an anti-inflammatory JNK inhibitor, and clofibrate have a synergistic effect in inducing cell responses and in affecting the gene expression profile, in CaCo-2 colon cancer cells. | 2012 | Angelo Cerbone; Cristina Toaldo; Stefania Pizzimenti; Piergiorgio Pettazzoni; Chiara Dianzani; Rosalba Minelli; Eric Ciamporcero; Guglielmo Roma; Mario Umberto Dianzani; Roberto Canaparo; Carlo Ferretti; and Giuseppina Barrera |